| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |